Janux Therapeutics Inc (JANX) support and resistance · rev $10.3M
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
This page maps Janux Therapeutics Inc (JANX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
JANX currently screens at market cap $1.49B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new JANX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the JANX quote page for the session range and the stock page for the full model.
Not investment advice.